142nd APHA Annual Meeting and Exposition

Home Events & Meetings Annual Meeting Schedule & Program

Online Program

Annual Meeting Recordings are now available for purchase

296819
Determination of HIV and Hepatitis C co-infection in Louisiana 2002-2012 through state disease registry matching

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Tuesday, November 18, 2014

Antoine Brantley, MPH , Department of Health and Hospitals Louisiana Office of Public Health STD/HIV Program, New Orleans, LA
William T. Robinson, PhD , School of Public Health, LSU Health Sciences Center, New Orleans, LA
Dielda Robertson , Louisiana Office of Public Health, New Orleans, LA
Sharell Westry-Lewis , Walden University, new orleans, LA
HIV and hepatitis C (HCV) share at least one common route of transmission. While both represent a serious health concern especially among persons who inject drugs (PWID), HIV/HCV co-infection introduces additional complication in the treatment and disease progression of both conditions. Most studies to date that attempt to characterize coinfection rates have been done either in clinic based populations or convenience samples of PWID. The current study identifies all HIV and HCV coinfections among any HIV or HCV cases reported to the state of Louisiana during 2002 to 2012.

Method: 

A series of registry matches were conducted between the Louisiana Electronic HIV/AIDS Reporting System and the Louisiana Hepatitis Registry. Probabilistic and deterministic methods were used to identify coinfected individuals. Linking variables used to identify matches included name, date of birth, address, sex, race and death date.

Results: 

Overall, co-infection with hepatitis C was found among 5.83% of the (18,714) persons living with HIV/AIDS (PLWHA) while 5.41% of the 33,954 HCV infected individuals were found to also have HIV. The highest coinfection was in 2004 when 20.5% of HCV cases were PLWHA. Co-infected individuals were more likely to be male, African American, over 45, living in urban areas and infected with HIV through injection drug use.

Conclusions:

A substantial proportion of persons living with HIV/AIDS were found to have received an HCV diagnosis. Injection drug users were particularly impacted. Strategies for linking large registry systems and reporting issues as well as Implications for the treatment of HCV/HIV coinfected individuals are discussed.

Learning Areas:

Public health or related research

Learning Objectives:
Evaluate validity of registy matching techniques Assess statewide HIV and HCV co infection in Louisiana Describe registry mathing procedures

Keyword(s): Hepatitis C, HIV/AIDS

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have worked as a data analyst on multiple federally funded grants awarded to the STD/HIV program for the state of Louisiana. Much of my work involves the use and development of strategies to assess disparities, risk factors, and state-wide interventions involving HIV transmission and HIV-related care.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 4285.0: HIV, Infectious Diseases, and Co-Morbidities